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Abstract: Chronic rhinosinusitis (CRS) is one of the most common persistent disorders of the devel-
oped world, requiring input from various specialists including primary care physicians, otolaryngol-
ogists, respiratory physicians, and allergologists. B-cell lymphoproliferative disorders (BLPDs) are a
heterogenous group of malignant conditions defined by an accumulation of mature B lymphocytes
in the bone marrow, blood, and lymphoid tissues. We present a case report of an elderly man with
rhinosinusitis-like symptoms and atypical features prompting further investigations that culminated
in a diagnosis of BLPD.
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1. Introduction
Chronic rhinosinusitis (CRS) is one of the most common persistent disorders of the de-
veloped world, requiring input from various specialists including primary care physicians,
otolaryngologists, respiratory physicians, and allergologists [1]. Current international
guidelines recommend that diagnosis is made by clinicians on the basis of symptoms such
as nasal blockage, discharge, facial pressure, and loss of smell for at least 12 weeks [2].
However, the diagnostic work up can be fraught with difficulty, especially when attempt-
ing to differentiate between CRS and allergic and nonallergic rhinitis on symptoms alone.
Additionally, not all patients with CRS criteria will have evidence of disease on nasal
endoscopy and CT imaging [2].
Based on high quality evidence, medical therapy with long term nasal corticosteroids,
short courses of oral corticosteroids, and/or nasal irrigation with isotonic saline or Ringer’s
lactate are effective in treating CRS [2]. Dupilumab (anti-IL4rα) is the only monoclonal
antibody approved for the treatment of CRS with nasal polyps (CRSwNP) at present. Two
studies have demonstrated efficacy of intravenous mepolizumab (anti-IL5) 750 mg q4w
on reducing the need for nasal polyp surgery and total polyp score [3,4] but at the current
subcutaneous licensed dose of 100 mg q4w, our experience has shown a clear disconnect in
response between severe eosinophilic asthma and CRSwNP [5]. Surgical management is
usually indicated when CRSwNP is refractory to medical therapy [2].
B-cell lymphoproliferative disorders (BLPDs) are a heterogenous group of malignant
haematological conditions with a significantly higher incidence in individuals with primary
or secondary immunodeficiency [6]. Diagnosis is usually made on the basis of clinical fea-
tures such as enlarged lymph nodes or splenomegaly and excess fatigue and/or apparent
cytopenia and lymphocytosis on a full blood count [7]. Morphological examination demon-
strating a lymphocytic increase or abnormality would prompt further immunophenotypic
investigations. Multiparameter flow cytometry on peripheral blood or bone marrow is a
rapid and efficient tool for the diagnosis of BLPDs [7].
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2. Case
A 72-year-old man was referred by his general practitioner for chronic bilateral nasal
congestion, worse at night, and purulent nasal secretions predominantly in the morning.
In addition to multiple courses of antibiotics, he had previously tried fluticasone furoate,
mometasone furoate, and beclomethasone dipropionate nasal sprays to no avail. He
retained his sense of smell and denied post-nasal drip, sneezing, breathlessness, or cough.
He had no history of excess fatigue, weight loss, or night sweats. His past medical history
included essential hypertension for which he was taking perindopril 2 mg once daily (OD)
and a previous cerebral infarction treated with clopidogrel 75 mg OD. He is an ex-smoker
with no relevant family history.
Nasal endoscopy (30◦ oblique rigid Hopkins 3.0 mm) performed in our rhinology
mega-clinic revealed an oedematous friable bleeding nasal mucosal surface with significant
crusting but no polyps per se. Biopsy samples were taken from the middle turbinate and
crusting was debrided. Nasal douching with saline/bicarbonate was recommended, and
he was treated with concurrent azithromycin 500 mg OD and prednisolone 25 mg OD for 5
and 7 days, respectively, pending further results.
Initial laboratory results and subsequent lymphocyte surface marker analysis are
presented in Table 1. Protein electrophoresis identified two monoclonal bands consistent
with IgM lambda and kappa bands quantifiable at 10 g/L. CT sinus scan (Figure 1) revealed
mucosal disease predominantly affecting the ethmoid bullae and ostiomeatal complex,
with a Lund Mackay score of 12. Apart from minor basal atelectasis, chest X-ray was
normal. Histopathology subsequently revealed chronic non-specific inflammatory changes
with mixed microbial flora abundant in gram-positive cocci.
Table 1. Laboratory results and lymphocyte surface marker analysis.
White Blood Cells (×109/L) 9.8 Corr. Calcium (mmol/L) 2.44
Haemoglobin (g/L) 136 C-reactive protein (mg/L) <4
Haematocrit (%) 41.3 Sodium (mmol/L) 141
Platelets (×109/L) 328 Potassium (mmol/L) 4.8
Neutrophils (×109/L) 5.4 Urea (mmol/L) 6.4
Lymphocytes (×109/L) 3.5 Creatinine (µmol/L) 86
Eosinophils (×109/L) 0.14 PR3/MPO antibodies negative
Plasma viscosity (mPa.s) 1.99 ↑ CTD screen negative
Total bilirubin (µmol/L) 5 RAST to ABCDH negative
ALT (U/L) 25 RAST to grass weakly positive
ALP (U/L) 110 Total IgE (kU/L) 89.5
Albumin (g/L) 36 IgG (g/L) 9.94 (NR 5.5–13)
Pneumococcal ab (mg/L) 52.64 IgA (g/L) 1 (NR 0.5–4)
IgM (g/L) 10.2 ↑ (NR 0.5–2.5)
CD3 (%) 88.57 ↑ CD19 (%) 3.53
CD3 (×106/L) 2922 ↑ CD19 (×106/L) 116
CD4 (%) 32.94 ↑ NK cells (%) 6.88
CD4 (×106/L) 1087 NK cells (×106/L) 227
CD8 (%) 53.6 ↑ CD4/CD8 ratio 0.62 ↓
CD8 (×106/L) 1769 ↑
A = aspergillus fumigatus; ALP = alkaline phosphatase; ALT = alanine aminotransferase; B = silver birch; C = cat
dander; CD = cluster of differentiation; CTD = connective tissue disease; D = dog dander; H = house dust mite;
MPO = myeloperoxidase; NK = natural killer; NR = normal range; PR3 = proteinase-3; RAST = radioallergosorbent
testing for specific IgE. ↑ and ↓ denote values outside NR.
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3. Discussion 
In this case report, we present a patient referred from primary care for CRS without 
nasal polyposis and suspicious atypical features who was subsequently diagnosed with 
low grade BLPD. To our knowledge, although there have been case series on localised 
sinonasal lymphoma [8,9], we have not yet encountered a case report of BLPD masquer-
ading as CRS. 
While the diagnosis of BLPD was clinical, the value of endobronchial ultrasound-
guided transbronchial needle aspiration (EBUS-TBNA) of mediastinal and hilar lymph 
nodes in the diagnosis of lymphoma is controversial [10] and hence a negative result 
would likely still mandate surgical mediastinoscopy confirmation. In the absence of B 
symptoms or abnormal full blood count, a watch and wait strategy is usually employed 
for low grade BLPDs and therefore no bone marrow or lymph nodes were sampled in our 
patient, to avoid unnecessary additional risk. 
The abundance of gram-positive cocci is likely to infer chronic staphylococcal infec-
tion, which in turn is highly suggestive of immunosuppression. Although the acute abun-
dance of gram-positive cocci commonly infers nasal colonisation with Streptococcus 
pneumoniae, failure to respond to recurrent courses of antibiotic therapy likely results in 
a selection pressure towards treatment resistant organisms such as Staphylococcus aureus 
[11]. Risk factors for S. aureus nasal colonisation depends on host factors but is more fre-
quent in conditions that result in immunosuppression such as in patients infected with 
human immunodeficiency virus (HIV) or those who are diabetic and undergoing dialysis 
[12]. The combination of immunosuppression, IgM paraproteinaemia, and extensive me-
diastinal and hilar lymphadenopathy is probably sufficient to make a clinical diagnosis of 
BLPD. 
The key learning point here is that although nasal crusting is a frequently encoun-
tered clinical feature that often requires no specific treatment, it is nevertheless crucial for 
the clinician to identify the small number of cases that are due to a potentially wide dif-
ferential diagnosis including systemic inflammatory disorders such as vasculitis, malig-
nancy, and infection, amongst others [13]. Clinicians should have a high index of clinical 
suspicion and our usual practice should be to check serum protein electrophoresis and 
immunoglobulins in all patients presenting with CRS-like symptoms and signs of immu-
nosuppression as it may lead to an earlier diagnosis and potentially better outcome for 
patients. 
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Our patient was consequently referred to haematology where on physical examination
there was no clinical evidence of palpable lymphadenopathy or hepat splenomegaly.
A CT chest-abdomen-pelv s scan (F gure 1) identified significant mediastinal an hilar
ymph nopathy and the c mbination of serum and r diological findings in turn made
the clinical diagnosis of B-cell lymphoprolif rative disorder (BLPD).
3. Discussion
In this case report, w present patient referred from primary care for CRS without
asal polyposis nd su picious atypical features who was subsequently di g osed with low
grade BLPD. To our k owl dge, although there have been case ser es on localised sinonasal
l h a [8,9], we h ve not yet enco tered ase report of BLPD masquerading as CRS.
While the diagnosis of BLPD was clinic l, the value of en obronchi l ultrasound-
guided transbronchial needle aspiration (EBUS-TBNA) of mediastinal and hilar lymph
nodes in the diag osis of ly phoma is controversial [10] and hence a negative result would
likely still mandate surgical mediastinoscopy confirmation. In the absence of B symptoms
or abnormal full blood count, a watch and wait strategy is usually employed for low grade
BLPDs and therefore no bone marrow or lymph nodes were sampled in our patient, to
avoid unnecessary additional risk.
The abundance of gram-positive cocci is likely to infer chronic staphylococcal infection,
which in turn is highly suggestive of immunosuppression. Although the acute abundance
of gram-positive cocci commonly infers nasal colonisation with Streptococcus pneumoniae,
failure to respond to recurrent courses of antibiotic therapy likely results in a selection
pressure towards treatment resistant organisms such as Staphylococcus aureus [11]. Risk
factors for S. aureus nasal colonisation depends on host factors but is more frequent in
conditions that result in immunosuppression such as in patients infected with human
immunodeficiency virus (HIV) or those who are diabetic and undergoing dialysis [12]. The
combination of immunosuppression, IgM paraproteinaemia, and extensive mediastinal
and hilar lymphadenopathy is probably sufficient to make a clinical diagnosis of BLPD.
The key learning point here is that although nasal crusting is a frequently encountered
clinical feature that often requires no specific treatment, it is nevertheless crucial for the
clinician to identify the small number of cases that are due to a potentially wide differential
diagnosis including systemic inflammatory disorders such as vasculitis, malignancy, and
infection, amongst others [13]. Clinicians should have a high index of clinical suspicion and
our usual practice should be to check serum protein electrophoresis and immunoglobulins
in all patients presenting with CRS-like symptoms and signs of immunosuppression as it
may lead to an earlier diagnosis and potentially better outcome for patients.
4. Conclusions
Patients with chronic rhinosinusitis who present with atypical clinical features such as
nasal crusting and treatment resistant organisms may have underlying immunosuppres-
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sion. Identifying this in a timely manner with further focused investigations may lead to
earlier diagnoses and better outcomes for patients.
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